Author

Yong Bin Kim

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abigail TwoyiD· 1 shared Alejandro Villar‐PradosiD· 1 shared Avnesh Sinh ThakoriD· 1 shared Bettina Panagiota IliopoulouiD· 1 shared Biki GuptaiD· 1 shared Cameron S. BaderiD· 1 shared Emily Soohoo· 1 shared Everett H. MeyeriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abigail TwoyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes

Shiva Pathak, Rizwan Ahmed, Nadine Nagy, Sooyeon Lee, Cameron S. Bader, Shobha Regmi, Bettina Panagiota Iliopoulou, Pin-I Chen, Biki Gupta, Alejandro Villar‐Prados, Yong Bin Kim, Noor A. Hussein, Emily Soohoo, Abigail Twoy, Avnesh Sinh Thakor, , Everett H. Meyer

The paper identifies CD38 as a marker for pathogenic T cells in T1D and shows that anti-CD38 mAb selectively depletes these cells to prevent diabetes without affecting Tregs.

bioRxiv · Jul 3, 2026 · PreprintImmunology